TrialEuropean journal of heart failure2017

Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study.

John R Teerlink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.